(1S,2S,3S,6R,7S,9S,12S)-1-hydroxy-12-methyl-5,8,10-trioxatetracyclo[5.4.1.02,6.03,9]dodecan-4-one

Details

Top
Internal ID 171e874c-e3b8-46bf-b600-8fabb8a9c9f3
Taxonomy Organoheterocyclic compounds > Furopyrans
IUPAC Name (1S,2S,3S,6R,7S,9S,12S)-1-hydroxy-12-methyl-5,8,10-trioxatetracyclo[5.4.1.02,6.03,9]dodecan-4-one
SMILES (Canonical) CC1C2C3C4C1(COC(C4C(=O)O3)O2)O
SMILES (Isomeric) C[C@H]1[C@H]2[C@H]3[C@H]4[C@@]1(CO[C@H]([C@H]4C(=O)O3)O2)O
InChI InChI=1S/C10H12O5/c1-3-6-7-5-4(8(11)14-7)9(15-6)13-2-10(3,5)12/h3-7,9,12H,2H2,1H3/t3-,4+,5-,6-,7+,9-,10-/m0/s1
InChI Key UCYJAMRRXNXQJP-GEXBLYTOSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C10H12O5
Molecular Weight 212.20 g/mol
Exact Mass 212.06847348 g/mol
Topological Polar Surface Area (TPSA) 65.00 Ų
XlogP -0.60
Atomic LogP (AlogP) -0.72
H-Bond Acceptor 5
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,2S,3S,6R,7S,9S,12S)-1-hydroxy-12-methyl-5,8,10-trioxatetracyclo[5.4.1.02,6.03,9]dodecan-4-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9811 98.11%
Caco-2 - 0.6339 63.39%
Blood Brain Barrier - 0.5500 55.00%
Human oral bioavailability + 0.5714 57.14%
Subcellular localzation Mitochondria 0.5984 59.84%
OATP2B1 inhibitior - 0.8575 85.75%
OATP1B1 inhibitior + 0.9279 92.79%
OATP1B3 inhibitior + 0.9507 95.07%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.9500 95.00%
BSEP inhibitior - 0.9641 96.41%
P-glycoprotein inhibitior - 0.9427 94.27%
P-glycoprotein substrate - 0.7605 76.05%
CYP3A4 substrate + 0.5176 51.76%
CYP2C9 substrate - 0.8063 80.63%
CYP2D6 substrate - 0.8805 88.05%
CYP3A4 inhibition - 0.9044 90.44%
CYP2C9 inhibition - 0.9693 96.93%
CYP2C19 inhibition - 0.9315 93.15%
CYP2D6 inhibition - 0.9382 93.82%
CYP1A2 inhibition - 0.8793 87.93%
CYP2C8 inhibition - 0.9744 97.44%
CYP inhibitory promiscuity - 0.9761 97.61%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.5540 55.40%
Eye corrosion - 0.9790 97.90%
Eye irritation - 0.7053 70.53%
Skin irritation - 0.6615 66.15%
Skin corrosion - 0.8701 87.01%
Ames mutagenesis + 0.6700 67.00%
Human Ether-a-go-go-Related Gene inhibition - 0.9028 90.28%
Micronuclear - 0.6241 62.41%
Hepatotoxicity + 0.5408 54.08%
skin sensitisation - 0.8462 84.62%
Respiratory toxicity - 0.5667 56.67%
Reproductive toxicity + 0.7444 74.44%
Mitochondrial toxicity + 0.6125 61.25%
Nephrotoxicity + 0.6455 64.55%
Acute Oral Toxicity (c) III 0.4157 41.57%
Estrogen receptor binding + 0.6480 64.80%
Androgen receptor binding - 0.6598 65.98%
Thyroid receptor binding - 0.6585 65.85%
Glucocorticoid receptor binding - 0.6800 68.00%
Aromatase binding - 0.8027 80.27%
PPAR gamma - 0.5186 51.86%
Honey bee toxicity - 0.8521 85.21%
Biodegradation + 0.5500 55.00%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity - 0.5559 55.59%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 88.66% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 88.65% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 84.99% 96.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 84.35% 99.23%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.15% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.84% 89.00%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 80.14% 96.77%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Gelsemium elegans

Cross-Links

Top
PubChem 101855970
LOTUS LTS0062289
wikiData Q105270230